Pre-Test Mitigating Cardiovascular Disease Risk Factors Pre-Test Cardiovascular disease is the leading cause of death for men and women in the United States, representing 1 in every _____ deaths 3 4 5 6 Unsure Which of the following has shown the most promise in mitigating CVD risk? EPA + DHA EPA only Fibrates Niacin Unsure Which of the following agents is the first EPA-only prescription product and the first FDA-approved medication to reduce cardiovascular risk beyond cholesterol-lowering therapy in high-risk adults? Atorvastatin Bezafibrate Icosapent ethyl Pemafibrate Unsure How confident are you in your ability to implement recent data, newer therapeutic strategies, and guideline-directed care in clinical practice to minimize CVD risk and improve patient outcomes? Very confident Confident Somewhat confident Not very confident Not at all confident
